Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Gives $300,000 to UCSD Scientist and Co-Founder for Nanotech Research

NEW YORK, Dec. 1 (GenomeWeb News) - Nanogen will provide $300,000 to support nanotechnology research at the Universityof California San Diego, the company said today.

 

Over a two-year period, Nanogen will fund the research of Michael Heller, a professor in the department of bioengineering at Jacobs School of Engineering at UCSD and a co-founder of Nanogen. He plans to explore the use of electric field-based technology for nanofabrication and the assembly of nanostructures as well as the integration of nanostructures with other devices.

 

Nanogen will have priority to obtain any intellectual property rights developed under the research agreement.

 

Nanogen said it holds over 40 USpatents and patent applications based on intellectual property developed by Heller.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.